Ivonescimab improves survival in advanced non-small cell lung cancer
1. Patients in the ivonescimab group demonstrated a significantly greater progression-free survival than those in the pembrolizumab group. 2. Grade...
Pulmonology
Reports of high-impact pulmonology studies by medical professionals
Motivational interviewing not effective in reducing rehospitalisation and improving patient activation among patients with respiratory failure
1. Standalone motivational interviewing post-discharge did not reduce rehospitalization in older multimorbid patients with heart failure or chronic obstructive pulmonary...
Characterization of increased aspiration pneumonia risk in patients with stroke
1. Aspiration pneumonia in post-stroke patients showed significantly increased 90-day mortality, longer hospital stays, and more cardiovascular events at one...
Coronary CT-angiography-guided management improves outcomes in patients with stable chest pain
1. Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to...
Depemokimab therapy reduces exacerbations in patients with severe eosinophilic asthma
1. In this randomized, placebo-controlled replicate trial, depemokimab decreased the annual rate of exacerbations among patients with severe eosinophilic asthma....
High flow nasal cannula reduces hypoxia for obese patients undergoing endoscopy
1. The use of high flow nasal cannula (HFNC) in patients with obesity undergoing sedated gastrointestinal endoscopy significantly reduced the...
Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease
Association between blood–urea–nitrogen-to-albumin ratio and in-hospital mortality in patients diagnosed with coronavirus disease 2019: a retrospective cohort study 1. Increased...
Different single inhaler triple therapies appear to have similar clinical outcomes for chronic obstructive pulmonary disease
1. In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was not associated with improved clinical...
Fractional dosing of pneumococcal conjugate vaccine noninferior to full dosing schedule
1. In this randomized non-inferiority trial, 40% of a full dose of the 13-valent pneumococcal conjugate vaccine (PCV13) was noninferior...
Reduced pneumococcal vaccine schedules non-inferior to WHO recommendations
1. In this cluster-randomized controlled trial, it was found that a pneumococcal conjugate vaccine (PCV) schedule involving a single primary...
